1. Home
  2. WVE vs NMIH Comparison

WVE vs NMIH Comparison

Compare WVE & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.19

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo NMI Holdings Inc.

NMIH

NMI Holdings Inc.

HOLD

Current Price

$35.68

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
NMIH
Founded
2012
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
WVE
NMIH
Price
$6.19
$35.68
Analyst Decision
Strong Buy
Buy
Analyst Count
16
4
Target Price
$29.81
$43.25
AVG Volume (30 Days)
3.9M
422.9K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.06
EPS
N/A
1.28
Revenue
$3,704,000.00
$706,440,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$85.67
$4.34
P/E Ratio
N/A
$28.02
Revenue Growth
149.43
8.52
52 Week Low
$5.02
$34.84
52 Week High
$21.73
$43.20

Technical Indicators

Market Signals
Indicator
WVE
NMIH
Relative Strength Index (RSI) 35.45 33.72
Support Level $6.02 $35.38
Resistance Level $7.65 $39.96
Average True Range (ATR) 0.35 0.80
MACD 0.05 -0.22
Stochastic Oscillator 15.04 0.63

Price Performance

Historical Comparison
WVE
NMIH

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

Share on Social Networks: